Immunomedics (IMMU) Resubmits BLA to FDA for Sacituzumab Govitecan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
Go back to Immunomedics (IMMU) Resubmits BLA to FDA for Sacituzumab Govitecan
December 5, 2019 5:51 AM EST
Immunomedics, Inc. (NASDAQ: IMMU) today announced the pricing of an... More